122033-62-9Relevant academic research and scientific papers
FUSED TRICYCLIC COMPOUNDS USEFUL AS ANTICANCER AGENTS
-
, (2020/09/19)
The specification relates to compounds of Formula (A) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
INDAZOLONES AS MODULATORS OF TNF SIGNALING
-
, (2016/11/02)
The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.
Tricyclic-pyridinylquinoline compounds, their preparation and use
-
, (2008/06/13)
Fluorinated 10-(2,6-dimethyl-4-pyridinyl)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids and -benzothiazine-6-carboxylic acids of the formula STR1 wherein R is hydrogen, R' is hydrogen or fluoro, R" is alkyl of 1-3 carbon atoms and X is O or S are superior antibacterial agents.
